<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03581396</url>
  </required_header>
  <id_info>
    <org_study_id>7026</org_study_id>
    <nct_id>NCT03581396</nct_id>
  </id_info>
  <brief_title>Scleral Hydrops and Intralabyrinthine Schwannoma</brief_title>
  <official_title>Scleral Hydrops and Intralabyrinthine Schwannoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The symptoms of intralabyrinthine schwannomas (vertigo, deafness, instability, tinnitus) cut
      across the symptoms found in pressure pathologies involving the inner ear, particularly the
      endolymphatic hydrops.

      Some publications have described dilatation of the membranous labyrinth (hydrops) in the
      presence of intralabyrinthine tumors.

      It would be interesting to measure the size of the saccule (structure of the membranous
      labyrinth) in the presence of an intralabyrinthine schwannoma, to evaluate if some of the
      symptoms presented by the patients could be explained by the concomitant presence of an
      endolymphatic hydrops (accessible to drug therapy - Betahistine).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 22, 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Size of intralabyrinth saccules</measure>
    <time_frame>1 hour after the realization of the MRI]</time_frame>
    <description>To measure saccule size (membranous labyrinth structure) in patients with intralabyrinthine schwannoma on a high resolution fluid sequence (FIESTA-C) in 3T MRI</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hydrops Saccular</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having benefited from an exploration of internal auditory canals by MRI in our
        service at CHU de Hautepierre between January 1, 2008 and October 1, 2017
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Age&gt; 18,

          -  Subject having benefited from an exploration of internal auditory canals by MRI in our
             service at CHU de Hautepierre between January 1, 2008 and October 1, 2017

          -  Presence on the MRI of the internal auditory ducts, including the realization of a
             high resolution fluid sequence of FIESTA-C (exploitable) type, of an intralabyrinthine
             schwannoma, without extension to the internal auditory canal.

          -  Subject who has agreed to the use of medical data for the purposes of this research.

        Criteria for Non Inclusion

          -  Refusal of the patient to participate in the study

          -  Absence of high resolution fluid sequence of fast imaging employing steady state
             acquisition (FIESTA-C)

          -  Presence of movement artifacts interfering with the interpretation of the FIESTA-C
             sequence

          -  Interior surgery of the inner ear or pontocerebellar angle, without preoperative
             imaging Inflammatory or infectious pathology of the concomitant middle or inner ear

          -  Extension of schwannoma to the internal auditory canal

          -  Impossibility of giving the subject informed information (difficulty understanding the
             subject,)

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aïna VENKATASAMY,, MD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>aina.venkatasamy@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service Imagerie 1</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aïna VENKATASAMY, MD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>aina.venkatasamy@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pauline BRETZ, MD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>paulinebretz@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Aïna VENKATASAMY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline BRETZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 26, 2018</study_first_submitted>
  <study_first_submitted_qc>June 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2018</study_first_posted>
  <last_update_submitted>June 26, 2018</last_update_submitted>
  <last_update_submitted_qc>June 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hydrops sacculaire</keyword>
  <keyword>schwannoma intralabyrinth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurilemmoma</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

